PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
0.79%
Growth of 0.79% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
-28.77%
Cost reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive advantage potential.
66.19%
Growth of 66.19% versus flat Healthcare gross profit. Walter Schloss would verify quality.
64.88%
Margin change of 64.88% versus flat Healthcare margins. Walter Schloss would verify quality.
-72.57%
R&D reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
6.30%
G&A change of 6.30% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
16.10%
Marketing expense change of 16.10% versus flat Healthcare spending. Walter Schloss would verify adequacy.
119.87%
Other expenses change of 119.87% versus flat Healthcare costs. Walter Schloss would verify efficiency.
7.55%
Operating expenses growth exceeding 1.5x Healthcare median of 0.48%. Jim Chanos would check for waste.
-16.92%
Total costs reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-35.94%
Interest expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
168.49%
D&A change of 168.49% versus flat Healthcare D&A. Walter Schloss would verify adequacy.
107.32%
EBITDA change of 107.32% versus flat Healthcare. Walter Schloss would verify quality.
-35.86%
EBITDA margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
131.77%
Operating income growth while Healthcare declines. Peter Lynch would examine advantages.
131.53%
Margin change of 131.53% versus flat Healthcare. Walter Schloss would verify quality.
67.77%
Other expenses growth exceeding 1.5x Healthcare median of 2.07%. Jim Chanos would check for issues.
96.02%
Income change of 96.02% versus flat Healthcare. Walter Schloss would verify quality.
96.05%
Margin change of 96.05% versus flat Healthcare. Walter Schloss would verify quality.
165.32%
Tax expense change of 165.32% versus flat Healthcare. Walter Schloss would verify strategy.
94.53%
Income change of 94.53% versus flat Healthcare. Walter Schloss would verify quality.
94.58%
Margin change of 94.58% versus flat Healthcare. Walter Schloss would verify quality.
94.63%
EPS change of 94.63% versus flat Healthcare. Walter Schloss would verify quality.
94.63%
Diluted EPS change of 94.63% versus flat Healthcare. Walter Schloss would verify quality.
0.77%
Share count reduction below 50% of Healthcare median of 0.33%. Jim Chanos would check for issues.
0.77%
Diluted share reduction below 50% of Healthcare median of 0.34%. Jim Chanos would check for issues.